We serve Chemical Name:phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone CAS:269410-03-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone](https://a.dearchem.com/CAS2/269410-03-9.png)
Chemical Name:phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone
CAS.NO:269410-03-9
Synonyms:bm268
Molecular Formula:C19H21BO3
Molecular Weight:308.17900
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:432.6ºC at 760mmHg
Density:1.11g/cm3
Index of Refraction:1.553
PSA:35.53000
Exact Mass:308.15800
LogP:3.21680
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like bm268 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bm268 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,bm268 Use and application,bm268 technical grade,usp/ep/jp grade.
Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone manufacturer The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone supplier Russia, which had temporarily stopped issuing work visas to Chinese citizens, is also halting visa-free entry for Chinese tour groups, the government said. Moscow has also stopped issuing electronic tourist visas to individual Chinese travelers. phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. phenyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone factory Retrogenix holds two Queen��s Awards for Enterprise, the UK��s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA.
